NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $46,000 | -67.6% | 82,929 | +7.8% | 0.00% | -62.5% |
| Q4 2018 | $142,000 | +69.0% | 76,918 | +72.1% | 0.01% | +60.0% |
| Q3 2018 | $84,000 | -53.8% | 44,690 | -67.2% | 0.01% | -37.5% |
| Q2 2018 | $182,000 | -87.0% | 136,177 | -87.9% | 0.01% | -89.2% |
| Q4 2017 | $1,395,000 | +12581.8% | 1,124,842 | +11061.4% | 0.07% | +7300.0% |
| Q3 2017 | $11,000 | -90.8% | 10,078 | -28.8% | 0.00% | -94.1% |
| Q4 2015 | $119,000 | -72.2% | 14,151 | -63.1% | 0.02% | -55.3% |
| Q2 2015 | $428,000 | – | 38,398 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |